"Dr. Ajai Chari Outlines Disparities and Treatment Patterns in Multiple Myeloma"
Ajai Chari, MD, associate professor, hematology and medical oncology at the Icahn School of Medicine at Mount Sinai, discusses multiple myeloma. “Research has shown disparities in multiple myeloma treatment between clinical trials and real-world outcomes, as well as a lot of heterogeneity among treatment patterns by age and region.” He added, “The disparities relate to the differences between clinical trials and real-world outcomes. So, in clinical trials we cherry picked really healthy patients.”
— Ajai Chari, MD, Director, Clinical Research in the Multiple Myeloma Program, Associate Director, Clinical Research, Mount Sinai Cancer Clinical Trials Office, Associate Professor, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai
Diabetes May Accelerate Blood Cancer Growth, Yet Survival Outcomes Differ by Race
Sep 29, 2023 View All Press ReleasesScientists Create Most Powerful, Accurate Tool Yet to Research Deadliest Blood Cancer
Apr 18, 2023 View All Press ReleasesStudy Identifies New Gene That Drives Colon Cancer
Oct 14, 2022 View All Press ReleasesMount Sinai Researchers Discover Genes That Predict Good Response to Blood Cancer Therapy
Jun 16, 2022 View All Press Releases